A Study to Evaluate the Long-term Safety of Patients With Advanced Lymphoid Leukemia Who Have Been Previously Administered With UCART19

Running, not enrolling · Phase 1

Conditions studied: Advanced Lymphoid Leukemia

In brief

The purpose of this study is to evaluate the long-term safety and efficacy of UCART19 administration to patients with advanced lymphoid leukemia.

Key facts

Study ID
NCT02735083
Run by
Institut de Recherches Internationales Servier
People needed
28
Starts
2021-03-10
Expected to finish
2028-09-01
Last updated by the study team
2025-04-11

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.